The global HPAPIs market is expected to reach USD 34.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period.
In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period.
To request a sample copy or view summary of this report, click the link below:
Further Key Findings From the Study Suggest:
Synthetic route of High PotencyAPIs dominated the overall market in terms of revenue share as of 2016 owing to presence of large manufacturers producing these type of molecules
Biotech HPAPI segment is expected to be the fastest growing and is expected to grow at a lucrative growth ratedue torising demand for cancer drugs and fueling research and developmentactivities pertaining to it
Innovative drug market dominated the overall drug type in 2016. Generic drug segment is expected to be the fastest growing segment. The factors attributing to its growth are patent expiration of various drugs and increasing demand for the cancer treatment
Contact outsourcing segment is anticipated to show lucrative growth as major pharmaceuticals are focused on rigorous research and development activities for new drug development
Oncology segment heldlargest revenue share as of 2016, due to increasing demand for anti-cancerous drugs
North America HPAPIs market held the largest market share as of 2016. Growing prevalence of chronic disease patients, and established research and development infrastructure for novel drug development are factors supporting to major share of this market
Patent expiration of major drugs in North American and European countries is anticipated to fuel market growth
Asia Pacific regional market is expected to register significant growth owing to growing investments in biotechnology sector and rapidly growing oncology market
The key players in the HPAPI market includeBristol-Myers Squibb, Sigma-Aldrich Corporation, Pfizer Incand Lonza among others
Extensive research and development activities carried out by market participants is also expected to augment the market growth
Grand View Research has segmented the High PotencyAPIsmarket on the basis of the product, manufactures, drug types, application, and region:
HPAPIs Product Outlook (Revenue, USD Million, 2014 - 2025)
HPAPIs Manufacturers Outlook (Revenue, USD Million, 2014 - 2025)
HPAPIs Drug Types Outlook (Revenue, USD Million, 2014 - 2025)
HPAPIs Application Outlook (Revenue, USD Million, 2014 - 2025)
HPAPIs Regional Outlook (Revenue, USD Million, 2014 - 2025)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."